[news 1999-2000]

Oct. 24, 2000: FDA grants investigational new drug status to Queen's University spinoff Neurochem for Fibrillex™
GO >>

Oct. 24, 2000: FDA approves novel therapy discovered by Queen's University researcher for treatment of common pre-cancerous skin lesions

GO >>

May 9, 2000: QUEEN'S-based venture, Neuroceptor, Inc., secures R&D investment for pain and brain diseases

GO >>

June 1999: Cytochroma, Allergan collaborate in drug discovery deal with US$5 m

GO >>

April 28, 1999: Kingston's high tech sector expands with $3 m investment in Molecular Mining Corp.

GO >>

Feb. 15, 1999: $7 m venture capital fund created to commercialize biotechnology discoveries at Queen's

GO >>